Glioblastoma Foundation Funds Program for Early Detection of Glioblastoma

On this Inaugural Glioblastoma Awareness Day, we are pleased to announce the initiation of a program to detect glioblastoma early.

Early detection of cancer is known to increase survival, and we believe a
comprehensive program to detect glioblastoma at an early stage is urgently needed.

To initiate the program, we are pleased to announce funding the laboratory of Chetan Bettegowda, M.D, PhD at Johns Hopkins Medical Center. Dr. Bettegowda is a neurosurgeon and he is a part of the team, including Drs. Kinzler and Vogelstein, at Johns Hopkins that recently developed a blood test for eight common cancers.

An early diagnostic test for glioblastoma will ensure that this cancer is caught as early as possible, making current treatments more effective until researchers can find better therapeutic options for glioblastoma.

We look forward to working with the team at Johns Hopkins as they develop an early diagnostic test for Glioblastoma.

To learn more about the technology they are using, please visit the link

Their technology uses cancer DNA to detect the presence of cancer in the blood for eight different tumor types. The team will also be exploring additional approaches for the early detection of glioblastoma, and we welcome input and new ideas from the scientific community at large.

We wish Dr. Bettegowda the best of luck in his endeavors to develop an early diagnostic tool for glioblastoma and would like to thank our supporters, donors, and friends, as well as Drs. Kinzler and Vogelstein for their work in this area and their input.

#TransformGlioblastoma #GlioblastomaFoundation #GlioblastomaAwarenessDay #July17

The current standard of care for glioblastoma consisting of radiation and chemotherapy is ineffective.

Help Us Transform Glioblastoma Therapy